Background: The fine balance of immunoglobulins (Ig) E, IgG1, IgG4 and IgA in healthy production is maintained by the interaction of B cells with adaptive and innate immune response. The regulation of toll-like receptors (TLRs)-driven innate and adaptive immune effector B-cell response and the role of mammalian telomeric TTAGGG repeat elements represent an important research area. Methods: Human PBMC and purified naive and memory B cells were stimulated with specific ligands for TLR2, TLR3, TLR4, TLR5, TLR7, TLR8 and TLR9 in the presence or absence of telomeric oligonucleotides. B-cell proliferation, differentiation and antibody production were determined. Results: TLR9 ligand directly activates naive and memory B cells, whereas TLR7 can stimulate them in the presence of plasmacytoid dendritic cells. Human B cells proliferate and turn into antibody-secreting cells in response to TLR3, TLR7 and TLR9, but not to TLR2, TLR4, TLR5 and TLR8 ligands. Stimulation of B cells with intracellular TLR3, TLR7 and TLR9 induced an activation cascade leading to memory B-cell generation and particularly IgG1, but also IgA, IgG4 and very low levels of IgE production. Mammalian telomeric oligodeoxynucleotide (ODN) significantly inhibited all features of TLR ligand-induced events in B cells including B-cell proliferation, IgE, IgG1, IgG4, IgA production, class switch recombination, plasma cell differentiation induced by TLR3, TLR7 and TLR9 ligands. Conclusion: B cells require specific TLR stimulation, T-cell and plasmacytoid dendritic cell help for distinct activation and Ig production profiles. Host-derived telomeric ODN suppress B-cell activation and antibody production demonstrating a natural mechanism for the control of overexuberant B-cell activation, antibody production and generation of memory.
The fine balance of immunoglobulins (Ig) E, IgG1, IgG4 and IgA is deviated to exuberant production of allergen-specific IgE and weak production of IgG4 in allergic individuals (1) . The interaction of the environmental factors including allergens and microbial components with innate and adaptive immune system results in the class switch recombination of immunoglobulins (2) . Cells of the innate immunity equipped with toll-like receptors (TLRs) have an immense capacity to recognize a diverse spectrum of microorganisms including bacteria, viruses, fungi and parasites (1) (2) (3) (4) . While TLR10 ligand is yet to be described in humans, the specific ligands of TLR1 to TLR9 drive innate and adaptive immune effector cells towards inflammation and microbicidal activity (3, 4) . TLR1, 2, 4, 5 and 6 are expressed on the cell surface, whereas TLR3, TLR7, TLR8 and TLR9 have been shown to be expressed in the endosomes of cells (3) (4) (5) (6) . The intracellular localization of the latter TLRs allows bacteria and virus to be degraded in the endosomes/lysosomes after engulfment and phagocytosis in the innate immune cells during infection. This process is induced by the association of double-stranded RNA to TLR3, single-stranded RNA to TLR7 and TLR8 and unmethylated CpG motifs containing DNA to TLR9 (4, (7) (8) (9) (10) (11) (12) . TLR distribution intensity in the immune system cells and ligands for TLR has a critical role to understand hostpathogen interactions and the effects on the adaptive immunity. TLR expression shows different aspects in mouse and human cells, especially in B cells. Mouse B cells proliferate and differentiate upon LPS and CpG stimulation (13, 14) , whereas human B cells respond to CpG (15) but not to LPS stimulation (16) .
Bacterial DNA contains immunostimulatory CpG motifs that stimulate dendritic cells, NK cells and B cells and lead to their proliferation, maturation and secretion of a variety of cytokines, chemokines and immunoglobulins (2, 17, 18) . It has been reported that suppressive ODN motifs can selectively block CpG-mediated immune activation. Suppressive motifs are rich in poly 'G' or 'GC' sequences and are present in the DNA of mammals and certain viruses. Suppressive oligodeoxynucleotides (ODNs) expressing arrays of the hexameric TTAGGG repetitive elements patterned after mammalian telomeres (19) have been demonstrated to block CpG-induced cytokine production in vitro and inhibit CpG-induced inflammatory reactions such as lethal endotoxic shock in mice (20) .
Therefore, we postulated that a natural inhibitory mechanism mediated by mammalian telomere motifs could help to restore B-cell homoeostasis. Stimulation of human PBMC via endosomal-associated TLRs as well as direct activation of naive or memory B cells with CpG ODN and plasmacytoid dendritic cell maturation by TLR7 induces polyclonal B-cell activation, proliferation and IgE, IgA IgG1 and IgG4 production suggesting a mechanism of immunological memory. are not an important source of IgE memory (21) . Here, we demonstrate that a synthetic analogue of mammalian telomeres containing four repeats of TTAGGG motif suppresses B-cell activation, proliferation and antibody production induced directly or indirectly by TLR3, TLR7 and TLR9 ligands.
Materials and methods

Isolation and purification of cells
PBMCs were obtained from heparinized whole blood or buffy coats from healthy individuals by Ficoll (Biochrom KG, Berlin, Germany) density gradient centrifugation. Cells were washed three times and resuspended in RPMI 1640 medium supplemented as previously described (22 Plasmacytoid dendritic cells were isolated from PBMC by positive selection using antibodies against BDCA-4 coupled to microbeads (FcRc) blocking reagent and the AutoMACS magnetic separation system (Miltenyi Biotec, Bergisch Gladbach).
Cultures of PBMC and B cells
Ligands for TLRs were Pam3-Cys-Ser-(Lys) 4 for TLR2 (Calbiochem AG, Laufelfingen, Switzerland), poly(I:C) for TLR3 (Amersham Biosciences, Lausanne, Switzerland), E. Coliderived lipopolysaccharide for TLR4 (Sigma Chem. Co., Buchs, Switzerland), flagellin for TLR5 (Calbiochem AG), 3M-001 for TLR7 (3M Pharmaceuticals, Minneapolis, MN, USA), 3M-002 for TLR8 (3M Pharmaceuticals) as described previously (23) and CpG2006 for TLR9 (Microsynth GmbH, Balgach, Switzerland). Phosphorothioate-modified ODNs were synthesized at the Microsynth GmbH, Balgach, Switzerland. Sequences of the phosphorothioate ODNs used were as follows: CpG2006 ODN: 5′-TCGTCGTTTGTCGTTTTGTCG TT-3′, control for immunostimulatory ODN (non-CpG): 5′-ATGCACTCTGCAGGCTTCTC-3′, telomeric ODN: 5′-TTAGGGTTAGGGTTAGGGTTAGGG-3′, base scrambled 'control ODN': 5′-ACATAGTCTCTCTCTAGTCAG TCT-3′. All reagents and ODNs used in this study contained <0.1 U/mg endotoxin. There was no cell toxicity of the ODN as investigated by annexin-V and 7-amino actinomycin D staining after 48 h up to 10 lM doses (24) . Recombinant IL-2 and IL-4 were from Novartis, Basel, Switzerland. Soluble CD40 ligand (sCD40L) was obtained from the transfected cell line 8-40-1 (sCD40L-CD8-a fusion protein; Institute for Immunology, Basel, Switzerland) (25). 5 9 10 5 PBMCs or purified naive or memory B cells were stimulated in 500 ll with different TLR ligands in 48-well plates (Costar Corporation, Cambridge, MA, USA). After initial experiments for dose optimization, Pam3-Cys-Ser-(Lys) 4 was used at 0.6 lM, poly(I:C) at 25 lg/ml, lipopolysaccharide at 100 ng/ml, flagellin at 1.8 lM, 3M-001 and 3M-002 at 1 lM, CpG2006 and control ODN at 1 lM. IL-2 was used at 4 ng/ml, IL-4 was 25 ng/ml, sCD40L was at 20% v/v as supernatant (26) 
Statistical analysis
Results are shown as mean AE SD. Nonparametric statistical comparison between groups was performed by Mann-Whitney U-test. The number of donors indicated in the figure legends includes all donors analysed in the relevant experiment.
Results
TLR3, TLR7 and TLR9 stimulations induce B-cell proliferation, which is suppressed by telomeric ODN Activation and clonal expansion of B cells is an essential event for immunoglobulin production. To investigate the role of different TLRs on human B-cell activation, proliferation and different isotypes of immunoglobulin production, we used different TLR-stimulated PBMCs, purified B cells and naive and memory B-cell subsets isolated from peripheral blood of healthy humans. First, PBMCs were stimulated with ligands of TLR2, TLR3, TLR4, TLR5, TLR7, TLR8 and TLR9 in the presence of IL-2 for 5 days. [ 3 H] thymidine incorporation was determined after 5 days. Ligands for TLR3, TLR7 and TLR9 induced significant cell proliferation. Human telomeric ODN significantly suppressed TLR3-, TLR7-and TLR9-mediated PBMC proliferation in a dosedependent manner (Fig. 1A ) reaching up to 60%, 90% and 80% inhibition at 5 lM doses, respectively (Supporting Information Fig. S1A ). For comparison, control ODN did not show significant suppressive activity (Fig. S1B ). Telomeric ODN, 1 lM, significantly suppressed PBMC proliferation stimulated by TLR3, TLR7 and TLR9 ligands (Fig. 1B) .
The next step was to identify the proliferating cell type within PBMC upon TLR3, TLR7 and TLR9 stimulations. Interestingly, stimulation of TLR3, TLR7 and TLR9 induced CD19 Regulation of class switch recombination and IgE, IgG1, IgG4, IgA production by TLR3, TLR7, TLR9 ligands and telomeric ODN B cells are continuously exposed to substances that stimulate the innate immune response from commensal flora bacteria in respiratory and gastrointestinal mucosas and they produce immunoglobulins against pathogens. After demonstration of the difference in TLR3-, TLR7-and TLR9-ligand-induced direct or indirect B-cell proliferation, we examined the effects of these ligands on AICDA mRNA expression and immunoglobulin synthesis by B cells and PBMC as well as the role of IL-2, IL-4 and sCD40L stimulation.
PBMCs were stimulated with ligands for TLR3, TLR7 and TLR9 in the presence and absence of telomeric ODN and control ODNs. IL-2, IL-4 and sCD40L were used to mimic T-cell help and promote B-cell clonal expansion. IgE, IgG1, IgG4 and IgA were measured on day 5 cell lysates (as mRNA) and day 12 culture supernatants ( Fig. 4A, B, C) . IgE antibody synthesis and Ie-Ce RNA transcripts expression were induced by TLRs in combination with IL-4 and sCD40L, but not induced with IL-2 and sCD40L in healthy individuals (data not shown).
As observed in B-cell proliferation, the profiles of immunoglobulin production showed differences in PBMC and purified B cells (Fig. 4A, B and Fig. S2 ). In PBMC, stimulation via TLR3, TLR7 and TLR9 even in the absence of IL-2 induced IgG1, IgG4 and IgA in detectable quantities. IL-2 significantly increased the synthesis of IgG1, IgG4 and IgA stimulated with TLR3, TLR7 and TLR9 ligands. Stimulation of cells with sCD40L had no significant effect on the production of immunoglobulins in the absence of IL-2, whereas IL-2 and sCD40L combination boosted IgG1 levels, and they had no additional contribution to the induction of IgG4 and IgA. Increased expression of Ic-Cc1, V H DJ H -Cc4 and Ia1/2-Ca1/2 RNA transcripts for IgG1, IgG4 and IgA in IL-2 and sCD40L-stimulated PBMC with TLR3, TLR7 and TLR9 verified our results (Fig. 4C) . Consistent with the proliferation studies, telomeric ODN significantly suppressed IgE, IgG1, IgG4 and IgA secretion and their mRNA expression independent of the type of TLR ligand in the presence of IL-4, IL-2 and sCD40L experimental conditions. Upon exposure to the infections or immunizations, activation-induced cytidine deaminase (AICDA) regulates class switch recombination and somatic mutation in B cells (29) . The expression of AICDA mRNA was measured after 5 days (Fig. 4D) . Telomeric ODN suppressed the expression of AICDA mRNA even in PBMC cultured with IL-2 + sCD40L and in combination with TLR3, TLR7 and TLR9 ligands. Control ODN did not show any stimulatory or inhibitory effect on the effect of TLR ligand and telomeric ODN.
We then investigated the effect of TLR3, TLR7 and TLR9 stimulation on antibody-forming cell frequency and whether it is also inhibited by telomeric ODN. Human PBMCs were stimulated with TLR3, TLR7 and TLR9 ligands in the presence of telomeric ODN, IL-2 and sCD40L. Secreted immunoglobulins were captured on ELISPOT plates between day 10 and day 11 of cultures. Stimulation via TLR3, TLR7 and TLR9 significantly increased IgG1, IgG4 and IgA producing cell frequency (Fig. 5A) . Particularly, a relatively high frequency of cells produced IgA after TLR3, TLR7 and TLR9 ligand stimulation. It has to be noted here that secreted their APC function was increased and some of them matured to antibody-forming cells (Fig. S3A) . 
CD19
+ expression. Surface CD138 expression, which is a highly and specific marker of plasma cells, was determined in 10 days of PBMC cultures with sCD40L + IL-4 and stimulated by TLR3, TLR7 or TLR9 alone or in combination with telomeric or control ODN. Stimulation with TLR3 or TLR7 ligands did not induce detectable CD138 expression, but TLR9 ligand induced its expression at the level of 1.6% of CD138 (Fig. 6A) . (Fig 6B, C) .
A C B
Discussion
The present study demonstrates that TLR3, TLR7 and TLR9 have distinct stimulatory pathways for B-cell activation and immunoglobulin production. We demonstrate here a synthetic analogue of mammalian telomeres suppresses direct and indirect effects of TLR3, TLR7 and TLR9 ligands as strong inducers of B-cell proliferation, differentiation and immunoglobulin production.
Here, we report that in addition to direct stimulation of B cells via TLR9, stimulation of PBMC via TLR3 and TLR7 indirectly leads to human B-cell proliferation and immunoglobulin production. Although TLR3, TLR7 and TLR9 are expressed at the same cellular location, in the endosomes, their expression rates differ depending on the type of the cells. In addition to TLR9, human peripheral blood B cells express high levels of TLR1, TLR6 and TLR10, intermediate levels of TLR7 and low levels of TLR2 and TLR4, but not TLR3 (28) . In the present study, we demonstrate that stimulation via TLR9 directly activates CD27 Whereas previous studies reported that TLR9 stimulation by CpG inhibited CD40/IL-4-driven IgE synthesis in human B cells and IgG1 and IgE synthesis in murine B cells (31, 32) . A recent study by Ozcan et al. (33) demonstrates that murine na€ ıve B cells were stimulated by TLR9 ligand with the cooperation of CD40, TACI and IL-4 produce IgG1 and IgE. PBMC stimulation via TLR3, TLR7 and TLR9 even in the absence of IL-2, IL-4 and sCD40L induced IgG1, IgG4 and IgA, in detectable quantities and IgE with the combination of IL-4 and sCD40L. In contrast to PBMC, purified human CD19 + B cells produce IgG1, IgG4 and IgA upon TLR9 stimulation but not TLR3 and TLR7 (Fig. S2) . The production of IgG1, IgG4 and IgA was increased by TLR3 and TLR7 in the presence of IL-2 and this response was boosted when combined with sCD40L, but sCD40L alone did not induce additive effect on purified B cells. The production of IgE by purified B cells was not induced by TLR3, TLR7 and TLR9 in the presence of IL-4 and sCD40L contrary to the findings in PBMC. The production amount of IgE by intracellular TLRs is not robust when compared to IgG1, IgG4 and IgA in PBMC and, moreover, was not detectable in human purified B-cell cultures. This finding suggests that intracellular TLR ligands may have a critical role in changing the balance against IgE and more in the direction of IgG1, IgG4 and particularly IgA in allergic diseases (26) .
In the present study, we investigated step by step all aspects of B-cell activation, proliferation, Ig class switch recombination, AICDA expression and plasma cell differentiation and demonstrated that mammalian telomeric ODN significantly suppressed all of the features. Suppression of B-cell activation and Ig production by suppressor ODN represents an important way for the treatment of diseases related to B-cell over activation. It can also be used for allergic diseases. Rituximab, a chimeric mAB to CD20, that efficiently eliminates circulating and overactive B cells that have CD20 on their surfaces and is therefore used to treat diseases characterized by high number of active B cells. A pilot study was already conducted in extrinsic atopic dermatitis characterized by highly elevated concentrations of IgE, and the early results of treatment with rituximab suggest that it may be a promising treatment option for patients with severe atopic dermatitis (34, 35) .
Previous studies have demonstrated that suppressor ODN possessing four repeats of TTAGGG motifs inhibits CpGinduced inflammation in mice (20, 36, 37) . Human telomeres consist of tandem repetitive arrays of the hexameric sequence TTAGGG (19) . The enzyme telomerase is a cellular ribonucleoprotein responsible for adding telomeric repeats onto the 3′ ends of chromosomes and thus compensates for cell division-associated telomere loss (37) . Elongation of telomeres with the telomerase results in an extended lifespan of a cell. Therefore, it was suggested that the length of the telomere rather than telomerase itself is responsible for limiting cell proliferation. Suppressive activity of TTAGGG motifs has been demonstrated to correlate with the ability of the sequence to form G-tetrads (18) . Individual mammalian cells contain phosphodiester TTAGGG motifs and some of them including some synthetic analogues are in single-stranded form. Therefore, it can be expected that high cellular concentrations of TTAGGG elements with suppressive capacity can be released to microenvironment following host cell death or following cell division. It is possible that self-DNA released by injured cells could down-regulate TLR-mediated inflammation response.
Another way to control TLR responses is the TLR tolerance phenomenon, which is explained by the unresponsiveness of the immune cells to the same or different TLR ligands upon the occurrence of repeated or chronic stimulation through TLRs (38) . The tolerant state in macrophages and B cells was associated with reduced NF-jB, MAPK activation and c-Jun phosphorylation (39) . However, B cells may receive general signals through TLRs and specific signals through BCR. The prestimulation of B cells with TLR7 may result in reduced B-cell proliferation and IgM secretion upon subsequent TLR7 restimulation, but simultaneous BCR signalling may prevent or reverse TLR7-or TLR9-mediated TLR tolerance in human B cells. This distinct response of TLRs and BCR to the TLR7 and TLR9 ligands may be a potential way to study the effects of telomeric ODNs on B-cell responses induced by TLR ligands. The TLR9 ligand, which is nucleic acid sequence, may bind to TLR9 localized in the endosomes. Telomeric ODNs that are also nucleic acid sequence too may have a potential to regulate B-cell response similar to the tolerance phenomenon that takes place by repeated or chronic stimulation through TLRs.
In both PBMC and B-cell cultures, mammalian telomeric ODN suppressed TLR3-, TLR7-and TLR9-ligand-induced B-cell proliferation without regarding direct or indirect stimulation. Whereas the generation of both TACI and BCMA positive and negative B cells were suppressed, the BAFFRexpressing B cells were resistant to suppression by telomeric ODN. Moreover, telomeric ODN significantly suppressed the proliferation of the antibody-forming cells. These findings were fully supported by demonstration of significant decrease in secreted Igs to the supernatants of PBMC and purified B cells by telomeric ODN. It remains to be elucidated whether the different levels of B-cell memory and serum antibodies to different pathogens depend on the amount of cell death and released telomeric ODN to the microenvironment during exposure and generation of the immune response.
It has been suggested that environmental stimuli such as CpG maintain continuous polyclonal memory B-cell activation, proliferation and differentiation (40) . In this way, a constant level of plasma cells and serum antibodies could theoretically be maintained throughout a human lifespan. Our study showed that in addition to CpG, TLR3 and TLR7 ligands have a capacity to induce B-cell activation in PBMC, which was significantly enhanced by IL-2. These findings demonstrate that direct or indirect stimulation of human B cells through endosomal-associated TLRs plays a pivotal role in polyclonal B-cell activation and immunoglobulin production to maintain long-term serological memory in humans. Suppression of this response by host-derived telomeric ODN suggests a natural mechanism to overcome hyperactivation of B cells and hyperproduction of immunoglobulins under chronic inflammatory conditions. The distinct effects of intracellular TLR3, TLR7 and TLR9 and telomeric ODN on B-cell activation, proliferation, AICDA expression, Ig class switch recombination, IgE, IgG1, IgG4, IgA production and plasma cell differentiation suggest a crucial role for the immunomodulation of B cell-mediated diseases as well as allergic inflammation.
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